Translational Development Acquisition Corp Warrants
TDACW
23 hedge funds and large institutions have $1.29M invested in Translational Development Acquisition Corp Warrants in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$131K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$129K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$104K |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$79.2K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$70.4K |
Top Sellers
TDACW Hedge Fund Activity: Q1 2025 in Review
23 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Translational Development Acquisition Corp Warrants (TDACW) for Q1 2025, worth a combined $1.29M.
Buyers outnumbered sellers: 23 funds opened new TDACW positions and 0 closed out — a net gain of 23 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AQR Arbitrage, opening a new position worth an estimated $131K.
- 23 institutional investors held Translational Development Acquisition Corp Warrants (TDACW) as of Q1 2025, up from 0 in Q4 2024.
- Funds reported $1.29M of Translational Development Acquisition Corp Warrants stock for Q1 2025.
- 23 funds opened new Translational Development Acquisition Corp Warrants positions in Q1 2025 and 0 closed out, a net change of +23 holders.
- The largest Translational Development Acquisition Corp Warrants buyer in Q1 2025 was AQR Arbitrage, an estimated $131K added.
Based on aggregated 13F filings for Q1 2025.